[Resolved]  Intas Pharmaceuticals / Espin 2. 5mg — 100% INCREASE IN MRP

I am an Angina patient taking regular medication. Yesterday I bought three packs of ESPIN 2.5MG ie.3 X 10 Tablet packs of Amlodipine 2.5mg tablets. While one pack's MRP was Rs.13.58 / 10 tabs (Mfg.dec 2008) while two packs's MRP was Rs.28.00 / 10 tabs, inclusive of all taxes (Mfg: April 2009)

It is surprising that a Tablet costing around 0.20 paise is being blatantly sold at Rs.2.80 per Tab. Also, where are the governmental agencies regulating Pricing of drugs like the NPPA / or the local drug departments? How come more than 100% increase in MRP has been allowed without any justification?
Can any consumer court take cognizance of this complaint and bring the pharma Companies to book for fleecing the patients like this???

I would request any of the concern authorities to initiate investigation into pricing and ensure that in these times of constraints, companies like Intas do not load the patients with unnecessary / unwarranted increase in prices.